Peripheral doses in radiotherapy: A comparison between IMRT, VMAT and Tomotherapy
暂无分享,去创建一个
Dirk Verellen | Filip Vanhavere | Ria Bogaerts | E. D'Agostino | Gilles Defraene | F. V. Heuvel | D. Verellen | M. Duchateau | F. Vanhavere | E. D'Agostino | R. Bogaerts | M. Duchateau | G. Defraene | L. de Freitas Nascimento | F Van den Heuvel | W. Schoonjans | W. Schoonjans | L. F. Nascimento
[1] Firas Mourtada,et al. The use of LiF (TLD‐100) as an out‐of‐field dosimeter , 2007, Journal of applied clinical medical physics.
[2] R. Cloutier. Tissue Substitutes in Radiation Dosimetry and Measurement. , 1989 .
[3] R. Harrison,et al. Organ doses from prostate radiotherapy and associated concomitant exposures. , 2006, The British journal of radiology.
[4] Harald Paganetti,et al. A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction , 2008, Physics in medicine and biology.
[5] J. Balog,et al. Helical tomotherapy radiation leakage and shielding considerations. , 2005, Medical physics.
[6] Chester R. Ramsey,et al. Out‐of‐field dosimetry measurements for a helical tomotherapy system† , 2006, Journal of applied clinical medical physics.
[7] R. Mohan,et al. The risk of developing a second cancer after receiving craniospinal proton irradiation , 2009, Physics in medicine and biology.
[8] E. Hall,et al. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. , 2003, International journal of radiation oncology, biology, physics.
[9] D. Kuban,et al. The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy. , 2005, International journal of radiation oncology, biology, physics.
[10] R. Upreti,et al. Estimation of risk of radiation-induced carcinogenesis in adolescents with nasopharyngeal cancer treated using sliding window IMRT. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[11] P. Olko,et al. Thermoluminescence Efficiency of LiF:Mg,Cu,P (MCP-N) Detectors to Photons, Beta-Electrons, Alpha Particles and Thermal Neutrons , 1994 .
[12] Andrew K. Lee,et al. Risk of secondary malignant neoplasms from proton therapy and intensity-modulated x-ray therapy for early-stage prostate cancer. , 2009, International journal of radiation oncology, biology, physics.
[13] M. Nieminen,et al. The applicability of radiophotoluminescence dosemeter (RPLD) for measuring medical radiation (MR) doses. , 2012, Radiation protection dosimetry.
[14] H. Paganetti,et al. Neutron equivalent doses and associated lifetime cancer incidence risks for head & neck and spinal proton therapy , 2009, Physics in medicine and biology.
[15] T. Kron,et al. Assessment of leakage doses around the treatment heads of different linear accelerators. , 2012, Radiation protection dosimetry.
[16] Hong-gi Kim,et al. Determinants of Economic Threshold for Powdery Mildew on Cucumber , 2006 .
[17] D Huyskens,et al. Peripheral neutron and gamma doses in radiotherapy with an 18 MV linear accelerator. , 2004, Radiation protection dosimetry.